ChengDu ShengNuo Biotec Revenue

ChengDu ShengNuo Biotec had revenue of 244.29M CNY in the quarter ending March 31, 2026, with 32.52% growth. This brings the company's revenue in the last twelve months to 801.40M, up 49.42% year-over-year. In the year 2025, ChengDu ShengNuo Biotec had annual revenue of 741.46M with 62.57% growth.

Revenue (ttm)

801.40M

Revenue Growth

+49.42%

P/S Ratio

7.31

Revenue / Employee

580.31K

Employees

1,450

Market Cap

5.86B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	741.46M	285.39M	62.57%
Dec 31, 2024	456.07M	21.05M	4.84%
Dec 31, 2023	435.02M	39.30M	9.93%
Dec 31, 2022	395.72M	9.19M	2.38%
Dec 31, 2021	386.53M	7.76M	2.05%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Luoxin Pharmaceuticals Group Stock	2.37B
Chongqing Pharscin Pharmaceutical	827.14M
Shanxi Zhendong Pharmaceutical Co.,Ltd	2.78B
Jinghua Pharmaceutical Group	1.46B
Shanghai Kaibao Pharmaceutical CO.,Ltd	1.04B
HPGC Renmintongtai Pharmaceutical	10.54B
Jiangsu Jibeier Pharmaceutical	990.68M
ChengDa Pharmaceuticals	458.30M

Revenue Rankings